Cargando…

Cardiovascular Effects of Cumulative Doses of Radioiodine in Differentiated Thyroid Cancer Patients with Type 2 Diabetes Mellitus

SIMPLE SUMMARY: The cardiovascular effects of radioiodine ((131)I) therapy on people with differentiated thyroid cancer (DTC) and concomitant type 2 diabetes mellitus (T2DM) are unknown. To the best of our knowledge, this study is the first of its kind. Our aim was to assess the relationship between...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stanciu, Adina Elena, Stanciu, Marcel Marian, Zamfirescu, Anca, Gheorghe, Dan Cristian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140142/ https://www.ncbi.nlm.nih.gov/pubmed/35625965 http://dx.doi.org/10.3390/cancers14102359

Ejemplares similares

Portrait of the Inflammatory Response to Radioiodine Therapy in Female Patients with Differentiated Thyroid Cancer with/without Type 2 Diabetes Mellitus
por: Stanciu, Adina Elena, et al.
Publicado: (2023)

TNF-α May Exert Different Antitumor Effects in Response to Radioactive Iodine Therapy in Papillary Thyroid Cancer with/without Autoimmune Thyroiditis
por: Gheorghe, Dan Cristian, et al.
Publicado: (2021)

Analysis of the Correlation between the Radioactive Iodine Activity and Neutrophil-to-Lymphocyte Ratio in Patients with Differentiated Thyroid Cancer
por: Stanciu, Adina Elena, et al.
Publicado: (2022)

Eustachian Tube Teratoma: A Rare Entity
por: Gheorghe, Dan Cristian, et al.
Publicado: (2023)

Moebius syndrome—Case report
por: Gheorghe, Dan Cristian, et al.
Publicado: (2022)

False-positive radioiodine uptake after radioiodine treatment in differentiated thyroid cancer
por: Barbaro, Daniele, et al.
Publicado: (2023)

Use of multikinase inhibitors/lenvatinib concomitant with radioiodine for the treatment of radioiodine refractory differentiated thyroid cancer
por: Herranz, Urbano Anido
Publicado: (2022)

Oxidative stress and radioiodine treatment of differentiated thyroid cancer
por: Buczyńska, Angelika, et al.
Publicado: (2021)

Feasibility of Apatinib in Radioiodine-Refractory Differentiated Thyroid Carcinoma
por: Du, Wei, et al.
Publicado: (2022)

Molecular Theranostics in Radioiodine-Refractory Differentiated Thyroid Cancer
por: Petranović Ovčariček, Petra, et al.
Publicado: (2023)

Cutaneous Manifestations Associated with Diabetes Mellitus—A Retrospective Study
por: Vâță, Dan, et al.
Publicado: (2023)

Radioiodine refractoriness score: A multivariable prediction model for postoperative radioiodine‐refractory differentiated thyroid carcinomas
por: Li, Genpeng, et al.
Publicado: (2018)

The EANM guideline on radioiodine therapy of benign thyroid disease
por: Campennì, Alfredo, et al.
Publicado: (2023)

Differentiated Thyroid Cancer: Management of Patients with Radioiodine Nonresponsive Disease
por: Busaidy, Naifa Lamki, et al.
Publicado: (2012)

Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer
por: Pacilio, Massimiliano, et al.
Publicado: (2022)

Radioiodine adjuvant therapy in differentiated thyroid cancer: An update and reconsideration
por: Sun, Yu-qing, et al.
Publicado: (2022)

Faecalibacterium prausnitzii in Differentiated Thyroid Cancer Patients Treated with Radioiodine
por: Fernandes, Ana, et al.
Publicado: (2023)

Defining Radioiodine-Refractory Differentiated Thyroid Cancer: Efficacy and Safety of Lenvatinib by Radioiodine-Refractory Criteria in the SELECT Trial
por: Kiyota, Naomi, et al.
Publicado: (2017)

Radiomics Analysis of [(18)F]FDG PET/CT Thyroid Incidentalomas: How Can It Improve Patients’ Clinical Management? A Systematic Review from the Literature
por: Gherghe, Mirela, et al.
Publicado: (2022)

Specific morphological aspects of the teeth and alveolar bone in Class II/2 malocclusion
por: Stanciu, Radu, et al.
Publicado: (2009)

The Romanian need of postgraduate specialization in dentistry considering the integration to the European Union
por: Dragos, Stanciu, et al.
Publicado: (2008)

Differential diagnosis of thyroid nodule capsules using random forest guided selection of image features
por: Eftimie, Lucian G., et al.
Publicado: (2022)

Use of multikinase inhibitors/lenvatinib in patients with high cardiovascular risk/vasculopathy and radioiodine refractory‐differentiated thyroid cancer
por: Jimenez‐Fonseca, Paula
Publicado: (2022)

Low Dose of Lenvatinib Treatment for Patients of Radioiodine-Refractory Differentiated Thyroid Carcinoma – A Real-World Experience
por: Jiang, He-Jiun, et al.
Publicado: (2021)

Radioiodine Therapy in Differentiated Thyroid Cancer: The First Targeted Therapy in Oncology
por: Chung, June-Key, et al.
Publicado: (2014)

Radioiodine treatment of differentiated thyroid cancer despite history of ‘iodine allergy’
por: Puchalski, Adam R, et al.
Publicado: (2014)

Sperm DNA fragmentation after radioiodine treatment for differentiated thyroid cancer
por: Esquerré-Lamare, Camille, et al.
Publicado: (2015)

Updates on the Management of Advanced, Metastatic, and Radioiodine Refractory Differentiated Thyroid Cancer
por: Tumino, Dario, et al.
Publicado: (2017)

Efficacy of Low-Dose Radioiodine Ablation in Low- and Intermediate-Risk Differentiated Thyroid Cancer: A Retrospective Comparative Analysis
por: Gómez-Pérez, Ana María, et al.
Publicado: (2020)

A Pilot Study on the Association between Cardiovascular Risk Factors and Coronary Artery Calcification in a Group of Patients Investigated via Cardiac Computed Tomography in a European Country with High Cardiovascular Risk
por: Capisizu, Adriana Sorina, et al.
Publicado: (2023)

Acute idiopathic polyradiculoneuritis concurrent with acquired myasthenia gravis in a West Highland white terrier dog
por: Stanciu, Gabriela Dumitrita, et al.
Publicado: (2016)

Acute Myeloid Leukemia after Low-Dose Radioiodine Therapy for Papillary Thyroid Carcinoma
por: Alsaud, Arwa, et al.
Publicado: (2020)

Thyrotrophin receptors, tumour radioiodine concentration and thyroglobulin secretion in differentiated thyroid cancers.
por: Edmonds, C. J., et al.
Publicado: (1985)

Personalized Medicine Based on Theranostic Radioiodine Molecular Imaging for Differentiated Thyroid Cancer
por: Ahn, Byeong-Cheol
Publicado: (2016)

Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer for Reapplication of I-131 Therapy
por: Hong, Chae Moon, et al.
Publicado: (2017)

Prognostic factors and the effect of radioiodine on patients with locally advanced differentiated thyroid cancer
por: Yao, Yao, et al.
Publicado: (2020)

Whole-Body Radioiodine Effective Half-Life in Patients with Differentiated Thyroid Cancer
por: Klain, Michele, et al.
Publicado: (2021)

Predictors of Response and Survival to Multikinase Inhibitors in Radioiodine Resistant Differentiated Thyroid Cancer
por: Feola, Tiziana, et al.
Publicado: (2021)

Strongly Radioiodine-Positive Pancreatic Adenocarcinoma Mimicking Metastasis of Differentiated Thyroid Cancer
por: Rosar, Florian, et al.
Publicado: (2022)

Cost-Effectiveness of Apatinib and Cabozantinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer
por: Shi, Bo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j26tuurh1oonn4km9bnv5st09c